The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

Korábbi kezelés

• Patients with IPMN that has been subjected to FNA or biopsy prior to the LINFU procedure

Más betegség

• Patient with known allergy to the microbubble contrast agent or secretin
  • Study Design Overview:

Életkor

• Patient under the age of 18 and over the age 90

Egyéb

• Contraindications to LINFU® as determined by study investigators:
  • Patient with uncorrectable coagulopathy
  • Patient that cannot undergo anesthesia due to cardiopulmonary contraindication as deemed by the anesthesiologist
  • Unstable medically (cardiopulmonary, neurologic, or cardiovascular status)
• Patients with pancreatic cystic neoplasms other than IPMN i.e. mucinous cystic neoplasms, serous cystic neoplasms and other rare cystic lesions
• Pregnant females will be excluded
• Patient that is unable to provide informed consent

• Both males and females will be enrolled and must be at least 18 years of age and under age of 90
• Patients with a documented history of IPMN by any imaging method.
• All patients must undergo contemporaneous imaging (within 90 days before or after the LINFU® procedure) with one or more of the following: EUS, CH-EUS, CEUS, MRI/MRCP, PET/CT, CT
• Patients undergoing EUS-FNA may be enrolled but the FNA must be performed after the LINFU® procedure
• Institutional Review Board (IRB)-approved consent must be signed by patients to participate in this study.